Literature DB >> 22648097

Laparoscopic surgery for palliative resection of the primary tumor in incurable stage IV colorectal cancer.

Hideaki Nishigori1, Masaaki Ito, Yuji Nishizawa, Atsushi Kohyama, Takamaru Koda, Kentaro Nakajima, Yusuke Nishizawa, Akihiro Kobayashi, Masanori Sugito, Norio Saito.   

Abstract

BACKGROUND: The purpose of the study was to evaluate the feasibility and efficacy of laparoscopic palliative resection in patients with incurable stage IV colorectal cancer.
METHODS: We reviewed 100 patients with incurable stage IV colorectal cancer who underwent palliative resection of the primary tumor between 2002 and 2009 at National Cancer Center Hospital East (NCCHE). Outcomes and postoperative course were compared between patients who underwent open and laparoscopic surgery.
RESULTS: Of the 100 patients, 22 were treated with a laparoscopic procedure and 78 underwent an open surgical procedure. There was no difference in the preoperative characteristics of the two groups. In the laparoscopic group, the mean operation time was significantly longer (177 vs. 148 min, p = 0.007) and the amount of blood loss was significantly lower (166 vs. 361 ml, p = 0.002). Postoperative complications occurred in 5 patients (22.7 %) after laparoscopic surgery and in 21 patients (26.9 %) after open surgery, with no significant difference between the two groups. Time to flatus, time to start of food intake, and hospital stay were all shorter after laparoscopic surgery (3.0 vs. 3.8 days, p = 0.003; 3.6 vs. 5.0 days, p < 0.001; and 12.0 vs. 15.0 days, p = 0.005; respectively). Significantly more patients in the laparoscopic group had >15 % lymphocytes on postoperative day 7 (p = 0.049). Overall survival rates were 73.7 and 75.5 % at 1 year after laparoscopic surgery and open surgery, respectively (p = 0.344).
CONCLUSIONS: A laparoscopic procedure should be considered for palliative resection of the primary tumor for incurable stage IV colorectal cancer, because the results of this study indicate that the procedure is safe and effective.

Entities:  

Mesh:

Year:  2012        PMID: 22648097     DOI: 10.1007/s00464-012-2323-3

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  28 in total

1.  Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial.

Authors:  Ruben Veldkamp; Esther Kuhry; Wim C J Hop; J Jeekel; G Kazemier; H Jaap Bonjer; Eva Haglind; Lars Påhlman; Miguel A Cuesta; Simon Msika; Mario Morino; Antonio M Lacy
Journal:  Lancet Oncol       Date:  2005-07       Impact factor: 41.316

2.  Postoperative lymphocyte percentage influences the long-term disease-free survival following a resection for colorectal carcinoma.

Authors:  Yasuo Yoneyama; Masaaki Ito; Masanori Sugitou; Akihiro Kobayashi; Yusuke Nishizawa; Norio Saito
Journal:  Jpn J Clin Oncol       Date:  2011-01-03       Impact factor: 3.019

3.  Palliative operations for colorectal cancer.

Authors:  J Mäkelä; K Haukipuro; S Laitinen; M I Kairaluoma
Journal:  Dis Colon Rectum       Date:  1990-10       Impact factor: 4.585

4.  Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial.

Authors:  Pierre J Guillou; Philip Quirke; Helen Thorpe; Joanne Walker; David G Jayne; Adrian M H Smith; Richard M Heath; Julia M Brown
Journal:  Lancet       Date:  2005 May 14-20       Impact factor: 79.321

5.  Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases.

Authors:  S Benoist; K Pautrat; E Mitry; P Rougier; C Penna; B Nordlinger
Journal:  Br J Surg       Date:  2005-09       Impact factor: 6.939

6.  Prospective randomized study of laparoscopic versus open colonic resection for adenocarcinoma.

Authors:  J G Stage; S Schulze; P Møller; H Overgaard; M Andersen; V B Rebsdorf-Pedersen; H J Nielsen
Journal:  Br J Surg       Date:  1997-03       Impact factor: 6.939

7.  Meta-analysis of survival of patients with stage IV colorectal cancer managed with surgical resection versus chemotherapy alone.

Authors:  A P Stillwell; P G Buettner; Y H Ho
Journal:  World J Surg       Date:  2010-04       Impact factor: 3.352

8.  A comparison of laparoscopically assisted and open colectomy for colon cancer.

Authors:  Heidi Nelson; Daniel J Sargent; H Sam Wieand; James Fleshman; Mehran Anvari; Steven J Stryker; Robert W Beart; Michael Hellinger; Richard Flanagan; Walter Peters; David Ota
Journal:  N Engl J Med       Date:  2004-05-13       Impact factor: 91.245

9.  Emergency surgery for colon carcinoma.

Authors:  Lane Smothers; Linda Hynan; Jason Fleming; Richard Turnage; Clifford Simmang; Thomas Anthony
Journal:  Dis Colon Rectum       Date:  2003-01       Impact factor: 4.585

10.  Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases.

Authors:  N C Tebbutt; A R Norman; D Cunningham; M E Hill; D Tait; J Oates; S Livingston; J Andreyev
Journal:  Gut       Date:  2003-04       Impact factor: 23.059

View more
  3 in total

1.  Multicenter study of short- and long-term outcomes of laparoscopic palliative resection for incurable, symptomatic stage IV colorectal cancer in Japan.

Authors:  Tomonori Akagi; Masafumi Inomata; Seigo Kitano; Koya Hida; Yoshiharu Sakai; Suguru Hasegawa; Yousuke Kinjo; Kenichi Yoshimura; Masaaki Ito; Yosuke Fukunaga; Akiyoshi Kanazawa; Hitoshi Idani; Masahiko Watanabe
Journal:  J Gastrointest Surg       Date:  2013-02-22       Impact factor: 3.452

Review 2.  Clinical safety and outcomes of laparoscopic surgery versus open surgery for palliative resection of primary tumors in patients with stage IV colorectal cancer: a meta-analysis.

Authors:  Min-Wei Zhou; Xiao-Dong Gu; Jian-Bin Xiang; Zong-You Chen
Journal:  Surg Endosc       Date:  2015-08-18       Impact factor: 4.584

Review 3.  Palliative care and end-stage colorectal cancer management: the surgeon meets the oncologist.

Authors:  Renato Costi; Francesco Leonardi; Daniele Zanoni; Vincenzo Violi; Luigi Roncoroni
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.